Several 1-[(arylidene)amino]adamantanes were synthesized and evaluated in vitro as antitumor agents against 60 human tumor cell lines. Some of these derivatives showed specificity for human leukemia cell lines and 1-[(2-bromobenzylidene)amino]adamantane (2) (NSC 631076-L), the most active compound, was selected by the Biological Evaluation Committee (BEC), for in vivo testing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cell lines
8
synthesis antitumor
4
antitumor activity
4
activity evaluation
4
evaluation 1-[arylideneamino]adamantanes
4
1-[arylideneamino]adamantanes 1-[arylideneamino]adamantanes
4
1-[arylideneamino]adamantanes synthesized
4
synthesized evaluated
4
evaluated vitro
4
vitro antitumor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!